Informatie:
Fout:
ID
34337
Beschrijving
Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2); ODM derived from: https://clinicaltrials.gov/show/NCT02509871
Link
https://clinicaltrials.gov/show/NCT02509871
Trefwoorden
Versies (1)
- 16/01/2019 16/01/2019 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 de janeiro de 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hormonal Therapy NCT02509871
Eligibility Hormonal Therapy NCT02509871
- StudyEvent: Eligibility
Similar models
Eligibility Hormonal Therapy NCT02509871
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
postmenopausal women
boolean
ID.2
Item
patients requiring hormonal treatment
boolean
ID.3
Item
who performance status 0-2
boolean
ID.4
Item
patients initially included in metaca (au882) protocol
boolean
ID.5
Item
affiliation to a social security scheme (or be the beneficiary of such a plan)
boolean
ID.6
Item
patients who signed the informed consent form
boolean
ID.7
Item
patients witg relapse, with metastases or other cancer
boolean
ID.8
Item
concurrent treatment with a drug test, or participation in a clinical trial within < 30 days
boolean
ID.9
Item
patients carrying an electronic medical device (eg pacemaker)
boolean
ID.10
Item
patients who refused to sign the consent form
boolean